1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).
出版信息
Infect Dis Obstet Gynecol. 2000;8(1):5-74. doi: 10.1155/S1064744900000028.
Abstract
摘要
相似文献
1
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).
Infect Dis Obstet Gynecol. 2000;8(1):5-74. doi: 10.1155/S1064744900000028.
2
1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.
Clin Infect Dis. 1997 Oct;25 Suppl 3:S313-35.
3
4
Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
Ann Intern Med. 2002 Sep 3;137(5 Pt 2):435-78. doi: 10.7326/0003-4819-137-5_part_2-200209031-00002.
5
1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
Clin Infect Dis. 2000 Apr;30 Suppl 1:S29-65. doi: 10.1086/313848.
6
Preface to the 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Service/Infectious Diseases Society of America.
Clin Infect Dis. 1997 Oct;25 Suppl 3:S299-312.
7
2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.
Infect Dis Obstet Gynecol. 2002;10(1):3-64. doi: 10.1155/S1064744902000029.
8
Prevention and treatment of common HIV-associated opportunistic complications.
Prim Care. 1997 Sep;24(3):561-74.
9
[Prophylaxis of opportunistic infections in HIV-infected patients].
Rev Pneumol Clin. 1993;49(2):77-86.
10
Update on opportunistic infections.
AIDS. 1991;5 Suppl 2:S195-202.
引用本文的文献
1
Pyrimethamine upregulates BNIP3 to interfere SNARE-mediated autophagosome-lysosomal fusion in hepatocellular carcinoma.
J Pharm Anal. 2024 Feb;14(2):211-224. doi: 10.1016/j.jpha.2023.05.014. Epub 2023 Jun 1.
本文引用的文献
1
Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Clin Infect Dis. 1999 May;28(5):1049-56. doi: 10.1086/514744.
2
The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.
JAMA. 1999 May 19;281(19):1822-9. doi: 10.1001/jama.281.19.1822.
3
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.
N Engl J Med. 1999 Apr 29;340(17):1301-6. doi: 10.1056/NEJM199904293401701.
4
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group.
Lancet. 1999 Apr 17;353(9161):1293-8. doi: 10.1016/s0140-6736(99)03287-0.
5
Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.
N Engl J Med. 1999 Apr 8;340(14):1063-70. doi: 10.1056/NEJM199904083401402.
6
Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy.
Lancet. 1999 Jan 16;353(9148):201-3. doi: 10.1016/S0140-6736(98)07204-3.
7
Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.
Clin Infect Dis. 1998 Dec;27(6):1369-75. doi: 10.1086/515018.
8
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Group.
N Engl J Med. 1998 Dec 24;339(26):1889-95. doi: 10.1056/NEJM199812243392604.
9
Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men.
J Infect Dis. 1998 Dec;178(6):1616-22. doi: 10.1086/314486.
10
Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis.
J Infect Dis. 1998 Oct;178(4):1126-32. doi: 10.1086/515658.
Zotero 插件